These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 30482261

  • 21. The polio-eradication programme and issues of the end game.
    Minor PD.
    J Gen Virol; 2012 Mar; 93(Pt 3):457-474. PubMed ID: 22128250
    [Abstract] [Full Text] [Related]

  • 22. Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.
    Qiu J, Yang Y, Huang L, Wang L, Jiang Z, Gong J, Wang W, Wang H, Guo S, Li C, Wei S, Mo Z, Xia J.
    Hum Vaccin Immunother; 2017 Jun 03; 13(6):1-10. PubMed ID: 28362135
    [Abstract] [Full Text] [Related]

  • 23. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
    Duintjer Tebbens RJ, Hampton LM, Thompson KM.
    BMC Infect Dis; 2016 Jun 01; 16():237. PubMed ID: 27246198
    [Abstract] [Full Text] [Related]

  • 24. Polio endgame: Lessons for the global rotavirus vaccination program.
    Jiang B, Patel M, Glass RI.
    Vaccine; 2019 May 21; 37(23):3040-3049. PubMed ID: 31027927
    [Abstract] [Full Text] [Related]

  • 25. Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan.
    Saleem AF, Mach O, Quadri F, Khan A, Bhatti Z, Rehman NU, Zaidi S, Weldon WC, Oberste SM, Salama M, Sutter RW, Zaidi AK.
    Vaccine; 2015 Jun 04; 33(24):2757-63. PubMed ID: 25917673
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The final stages of the global eradication of polio.
    John TJ.
    N Engl J Med; 2000 Sep 14; 343(11):806-7. PubMed ID: 10984572
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Experience With Inactivated Polio Vaccine Introduction and the "Switch" From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization's Western Pacific Region.
    Gurung S, Harris JB, Eltayeb AO, Hampton LM, Diorditsa S, Avagyan T, Schluter WW.
    J Infect Dis; 2017 Jul 01; 216(suppl_1):S101-S108. PubMed ID: 28838170
    [Abstract] [Full Text] [Related]

  • 32. Polio endgame: the global introduction of inactivated polio vaccine.
    Patel M, Zipursky S, Orenstein W, Garon J, Zaffran M.
    Expert Rev Vaccines; 2015 May 01; 14(5):749-62. PubMed ID: 25597843
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Trade-offs of different poliovirus vaccine options for outbreak response in the United States and other countries that only use inactivated poliovirus vaccine (IPV) in routine immunization.
    Thompson KM, Kalkowska DA, Kidd SE, Burns CC, Badizadegan K.
    Vaccine; 2024 Feb 06; 42(4):819-827. PubMed ID: 38218668
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
    Immunization Systems Management Group of the Global Polio Eradication Initiative.
    MMWR Morb Mortal Wkly Rep; 2015 Jul 03; 64(25):699-702. PubMed ID: 26135591
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.